From Staff
A Brownstone Journal article alleges that federal health officials understated the volume of vaccine injury reports during the early COVID-19 vaccine rollout. The claims raise questions about data processing, public communication and the limitations of vaccine safety monitoring.
The U.S. Centers for Disease Control and Prevention (CDC) is facing renewed scrutiny over its handling of early COVID-19 vaccine safety data following allegations that the agency reassured the public while its reporting contractor struggled to process a surge in adverse-event reports.
In an October 28 article titled “How the CDC Lied about Shot Injury,” Jeffrey A. Tucker of the Brownstone Journal argues that federal officials failed to adequately disclose the backlog affecting the Vaccine Adverse Event Reporting System (VAERS) during the initial months of the COVID-19 vaccination campaign.
The article focuses on a January 15, 2021, memo from General Dynamics Information Technology (GDIT), the contractor responsible for processing VAERS reports. According to the memo quoted by Tucker, incoming COVID-19 vaccine reports had significantly exceeded the anticipated maximum of 1,000 reports per day, preventing the contractor from meeting established processing and response timeframes.
Tucker argues that the warning should have prompted an immediate reassessment of the vaccination campaign and more cautious public statements about vaccine safety.
On February 19, 2021, the CDC published an early assessment of COVID-19 vaccine safety in its Morbidity and Mortality Weekly Report (MMWR).
The report examined 6,994 VAERS reports received between December 14, 2020, and January 13, 2021. Its authors described the initial safety findings as reassuring and reported no unexpected patterns of serious adverse events.
Tucker contends that the assessment provided an incomplete picture because the number of reports discussed in the publication was substantially lower than the total number of reports he says had accumulated by that time.
He argues that the public-facing conclusions did not adequately communicate the implications of the processing backlog or the limitations of the available data.
However, the distinction between reports received and reports processed is critical. VAERS data undergo processing and review, and the number of reports analyzed in a published assessment does not, by itself, establish that officials concealed injuries or knowingly misrepresented vaccine safety. Establishing deliberate deception would require additional evidence concerning what officials knew, when they knew it and how they interpreted the available information.
The Brownstone Journal article also challenges the CDC's reporting of serious adverse events and deaths.
According to Tucker, approximately 9.2% of the reports examined in the early assessment were classified as serious. He uses that percentage to argue that thousands of serious events may have been represented in the larger pool of reports.
The article further cites approximately 966 death reports in VAERS by mid-February 2021, contrasting that figure with the 113 deaths discussed in the CDC assessment. The CDC report stated that available information did not suggest a causal relationship between vaccination and those deaths.
These figures require careful interpretation. VAERS is a passive surveillance system that accepts reports of health events occurring after vaccination, including events that may be coincidental or unrelated to the vaccine. A report is not, by itself, proof that a vaccine caused an injury or death.
Likewise, a report's classification as serious does not establish causation. Determining whether a vaccine caused a particular outcome requires further clinical and epidemiological assessment.
Nevertheless, the scale of incoming reports and the ability of surveillance systems to process them promptly are legitimate subjects for public scrutiny.
VAERS was designed to identify potential vaccine safety signals, not to independently establish the frequency of vaccine injuries or prove causation. The system can receive reports from healthcare professionals, manufacturers and members of the public, and its data can contain incomplete information, duplicate submissions and unverified claims.
Public health authorities have also acknowledged that passive reporting systems may capture only a fraction of adverse events.
Tucker argues that this limitation makes the reported figures an incomplete measure of the potential harm associated with COVID-19 vaccination. He also contends that the CDC's reassuring public statements failed to convey sufficient uncertainty during the rollout.
The broader issue is whether the agency communicated the limitations of its surveillance systems clearly enough while evidence was still emerging. That question is distinct from whether the available reports establish the article's allegations of deliberate deception.
The article raises concerns about the relationship between the CDC, its contractors and the pharmaceutical companies that developed COVID-19 vaccines. It also criticizes the legal protections afforded to manufacturers under the emergency public health framework.
During the pandemic, the Public Readiness and Emergency Preparedness (PREP) Act provided significant liability protections for covered countermeasures, subject to statutory conditions and exceptions. Emergency Use Authorization (EUA), meanwhile, allowed the Food and Drug Administration to authorize certain medical products during a declared emergency under a separate legal framework. These mechanisms did not eliminate all regulatory requirements.
Tucker argues that the combination of limited liability, vaccine mandates and public assurances created an environment in which potential safety concerns did not receive sufficient attention.
His article calls for accountability and renewed examination of the records surrounding the early vaccine rollout. However, the claims that officials deliberately lied, that the contractor's backlog proves widespread vaccine-caused injury, or that the reported deaths were caused by vaccination require independent corroboration.
The allegations underscore several questions that warrant examination: How quickly were incoming VAERS reports processed in early 2021? What did CDC officials know about the backlog when they issued public safety assessments? Were the limitations of the available data adequately disclosed? And did subsequent analyses identify safety signals that required changes in public health guidance?
Answering these questions requires examination of the original GDIT memo, contemporaneous processing records, the complete CDC report, internal agency communications and independent safety studies.
The early COVID-19 vaccine rollout unfolded under extraordinary public health pressures, with officials balancing the urgent need to reduce severe disease against the need to monitor products introduced at unprecedented speed.
Whether the CDC's early communications adequately reflected the uncertainty of that period remains an important question. Determining whether those communications amounted to deliberate deception, however, requires evidence beyond a reporting backlog or the number of adverse event reports alone.
Sources:
How the CDC Lied about Shot Injury
https://brownstone.org/articles/how-the-cdc-lied-about-shot-injury/
The Medical and Ethical Atrocity of “Perioperative Vaccination”
https://brownstone.org/articles/the-medical-and-ethical-atrocity-of-perioperative-vaccination/
Equity with Accountability in Pandemic Preparedness
https://brownstone.org/articles/equity-with-accountability-in-pandemic-preparedness/
No comments:
Post a Comment